investor harm

Class action lawsuit filed against Fitness Champs ($FCHL) alleging market manipulation via social media fraud. Investors have until June 16, 2026 to seek lead plaintiff status.

Class action lawsuit filed against $AQST alleging executives made false statements about Anaphylm FDA approval timeline and concealed human factors risks.

Class action lawsuit filed against $UPST alleging false statements about Model 22 AI underwriting capabilities and overstated accuracy rates during May-November 2025 period.

Class action lawsuit filed against Vital Farms for allegedly misleading investors about ERP system delays that caused company to miss 2025 earnings guidance.

Class action lawsuit filed against Navan alleging its October 2025 IPO prospectus contained false statements about sales and marketing expense requirements.

Class action lawsuit filed against Grocery Outlet alleging securities fraud, false financial statements, and unsustainable expansion strategy during August 2025-March 2026 period.

Class action lawsuit filed against Coty Inc. alleging executives made false statements about growth prospects. Investors claim company concealed slowing beauty market growth and margin pressures.

Stellantis faces class action lawsuit alleging materially false statements on earnings forecasts and EV strategy. Investors who bought stock between February 2025 and February 2026 may participate.

Class action alleges Eos Energy ($EOSE) executives hid production capacity issues, manufacturing delays, and quality control problems from investors between November 2025 and February 2026.

Law firm files class action against Concorde International Group alleging false statements, social media manipulation, insider share dumping, and artificial trading activity.

Class action lawsuit filed against $BSX alleging materially false statements about electrophysiology segment growth. Investors from July 2025-February 2026 may be eligible.

Class action lawsuit filed against AMC Entertainment over alleged materially false statements regarding APE preferred equity units and distribution rights following August 2023 conversion.

Class action lawsuit filed against Alight, Inc. alleging executives made false statements about CEO transition, capital returns, and revenue targets. Investors urged to act by May 15, 2026 deadline.

Class action lawsuit filed against $IBRX alleging false statements about Anktiva capabilities and business prospects during January-March 2026.

Class action lawsuit filed against $LAKE alleging executives made false statements about business operations and overstated subsidiary performance between December 2023 and December 2025.

Class action lawsuit filed against $SMCI alleges failure to disclose significant Chinese sales violating U.S. export controls and concealing compliance weaknesses.

Class action lawsuit filed against $SNOW alleging securities fraud over undisclosed efficiency changes and CEO resignation between June 2023 and February 2024.

Class action lawsuit filed against $APO over alleged false statements regarding Jeffrey Epstein connections and undisclosed reputational risks.

Lawsuit filed against $CORT alleging executives made false statements about relacorilant's clinical strength and FDA approval prospects, concealing regulatory concerns.

Class action lawsuit filed against New Era Energy & Digital ($NUAI) alleging material misstatements about Texas data centers and fraudulent oil/gas dealings.